2 completed, 2 recruiting, 1 active not recruiting, 1 terminated. 8 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 2, Recruiting 2, Active not recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Ascites Hepatic: new trials by email Literature Review of Ascites Hepatic trials Research Report on Ascites Hepatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| "Exploring the Potential Benefits of Using Dapagliflozin in Cirrhotic Chronic Liver Disease Patients- A Randomized Controlled Trial" Dapagliflozin - Ascites Hepatic | Phase 2 / Phase 3 | Recruiting | Beni-Suef University | 52 | 2026-07-01 | 2026-07-06 |
| Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites Albumin infusion (25% albumin), Normal Saline (0.9% NaCl) - Cirrhosis, Ascites Hepatic | Phase 2 | Recruiting | Anahita Rabiee MD MHS | 20 | 2025-02-28 | 2025-03-11 |
| Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome Ambrisentan, Terlipressin - Hepatorenal Syndrome, Liver Cirrhosis | Phase 2 | Active not recruiting | Noorik Biopharmaceuticals AG | 54 | 2024-04-17 | 2026-04-13 |
| Empagliflozin as a Novel Therapy in Refractory Ascites Empagliflozin 10 MG, Diuretics - Ascites Hepatic | Phase 2 / Phase 3 | Completed | Alexandria University | 42 | 2022-04-21 | 2022-11-29 |
| Sodium-glucose Linked Transporter 2 (SGLT-2) Inhibitors in Recurrent Ascites: a Pilot RCT Dapagliflozin (10Mg Tab) along with standard medical therapy, Placebo of dapaglifozin along with standard medical therapy - Cirrhosis, Ascites Hepatic | Phase 2 | Unknown | Post Graduate Institute of Medical Education and Research, Chandigarh | 44 | 2021-09-03 | 2021-09-05 |
| Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide. Ularitide, Placebo - Cirrhosis, Liver, Ascites Hepatic | Phase 2 | Terminated | University of Aarhus | 17 | 2020-08-01 | 2023-05-18 |
| Fresh Frozen Plasma as a Substitute for Albumin in Patients Receiving a Large Volume Paracentesis Fresh Frozen Plasma (FFP), Albumin, Large Volume Paracentesis (LVP) - Liver Cirrhosis, Ascites Hepatic | Phase 2 | Withdrawn | Montefiore Medical Center | 2019-11-11 | 2022-08-25 | |
| Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory Ascites Terlipressin acetate continuous infusion - Cirrhosis, Ascites Hepatic | Phase 2 | Completed | BioVie Inc. | 6 | 2017-07-15 | 2021-07-13 |
Fibrosis (4) · Liver Cirrhosis (3) · Ascites (2) · Acute Kidney Injury (1) · Hepatorenal Syndrome (1)
Pathologic Processes (6) · Pathological Conditions, Signs and Symptoms (6) · Digestive System Diseases (3) · Liver Diseases (3) · Fibrosis (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Renal Insufficiency (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Albumins (2) · Terlipressin (2) · dapagliflozin (2) · Diuretics (1) · Saline Solution (1) · Tablets (1) · Ularitide (1) · ambrisentan (1) · empagliflozin (1)
Alexandria University (1) · Anahita Rabiee MD MHS (1) · Beni-Suef University (1) · BioVie Inc. (1) · Montefiore Medical Center (1) · Noorik Biopharmaceuticals AG (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · University of Aarhus (1)
Egypt (2) · India (2) · United States (2) · Denmark (1)
Iker Navarro, MD (1) · Patrick Yeramian, MD (1) · Samuel Sigal, MD (1)
2019 (2)